Opthea (ASX:OPT) said that there remained material uncertainty as to its ability to continue as a "going concern," according to a Wednesday Australian bourse filing.
The company noted it continues an active discussion with investors as required by a development funding agreement to explore possible options to deliver the best outcome for the firm and its shareholders.
The firm said it plans to use the net proceeds from any current or future offering or capital raise to advance clinical development, chemistry, manufacturing and controls, regulatory activities of any new asset, and for general corporate purposes.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。